MICHELE MORGAN: Open Payments
NPI 1922482561 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,219 in 206 payments from 11 companies in 2025. Trend: 2023 $1,294 · 2024 $1,727 · 2025 $3,219
Food & beverage: $3,219
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 42 | $668 |
| Neurocrine BioSciences, Inc. | 44 | $537 |
| Otsuka America Pharmaceutical, Inc. | 21 | $437 |
| Janssen Pharmaceuticals, Inc | 17 | $367 |
| Teva Pharmaceuticals USA, Inc. | 18 | $337 |
| Alkermes, Inc. | 21 | $256 |
| Lundbeck LLC | 14 | $168 |
| E.R. Squibb & Sons, L.L.C. | 11 | $166 |
| ABBVIE INC. | 11 | $157 |
| Axsome Therapeutics, Inc. | 4 | $75 |
Products named: CAPLYTA, INGREZZA, ARISTADA, UZEDY, ABILIFY MAINTENA, SPRAVATO, REXULTI, ABILIFY ASIMTUFII.
Industry payments across VA — which companies pay providers there.
